Showing results (71-80 of 116) with videos related to
Sort By:
Pageof 12
Annals of Internal Medicine|October 7, 2024
Diabetes Risk Factors in People With HIV Receiving Pitavastatin Versus Placebo for Cardiovascular Disease Prevention : A Randomized TrialKathleen V Fitch, Markella V Zanni, Jennifer Manne-Goehler, et al.The Journal of the Association of Nurses in AIDS Care : JANAC|July 31, 2026
HIV-Related Stigma and Its Associated Factors Among Adults With HIV in Botswana, China, Colombia, Kenya, Nigeria, South Africa, Thailand, and the United States: A Cross-Sectional Quantitative StudyMotshedisi Sabone, Lefitile Lekone, Kathleen Nokes, et al.AIDS (London, England)|July 28, 2023
Hepatic steatosis and nonalcoholic fatty liver disease are common and associated with cardiometabolic risk in a primary prevention cohort of people with HIVJordan E Lake, Jana Taron, Heather J Ribaudo, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|April 12, 2022
Asymptomatic SARS-CoV-2 Infection Is Common Among ART-Treated People With HIVEdgar T Overton, Isabelle R Weir, Markella V Zanni, et al.American Heart Journal|April 1, 2019
Rationale and design of the Randomized Trial to Prevent Vascular Events in HIV (REPRIEVE)Steven K Grinspoon, Kathleen V Fitch, Edgar Turner Overton, et al.The Journal of Infectious Diseases|July 10, 2020
Characteristics of REPRIEVE Trial Participants Identifying Across the Transgender SpectrumLaura M Smeaton, Emma M Kileel, Beatriz Grinsztejn, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 24, 2023
Changes in Body Mass Index with Longer-term Integrase Inhibitor Use: A Longitudinal Analysis of Data from the Randomized Trial to Prevent Vascular Events in Human Immunodeficiency Virus (REPRIEVE)Emma M Kileel, Carlos D Malvestutto, Janet Lo, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 26, 2025
Risk Assessment in a Global CVD Prevention Cohort of People with HIV by PCE, PREVENT, and SCORE2Steven K Grinspoon, Sophia Zhao, Esteban Martinez, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 16, 2021
Cardiovascular Risk and Health Among People With Human Immunodeficiency Virus (HIV) Eligible for Primary Prevention: Insights From the REPRIEVE TrialPamela S Douglas, Triin Umbleja, Gerald S Bloomfield, et al.Blood Advances|January 10, 2024
Risk factors for clonal hematopoiesis of indeterminate potential in people with HIV: a report from the REPRIEVE trialRomit Bhattacharya, Md Mesbah Uddin, Aniruddh P Patel, et al.Pageof 12